Sorrento Therapeutics logo
Sorrento Therapeutics SRNE
$ 0.27 -29.58%

Quarterly report 2023-Q1
added 05-15-2023

report update icon

Sorrento Therapeutics EBITDA per Share 2011-2024 | SRNE

Annual EBITDA per Share Sorrento Therapeutics

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-1.32 -0.859 -1.44 -1.19 0.775 -1.17 -1.32 -1.21 -0.989 -0.4 -0.311

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
0.775 -1.44 -0.858

Quarterly EBITDA per Share Sorrento Therapeutics

2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
-0.19 - -0.22 -0.28 -0.31 - -0.31 -0.33 -0.29 - -0.3 -0.19 -0.22 - -0.34 -0.36 -0.98 - -0.36 -0.24 -0.36 - 1.33 -0.15 -0.43 - -0.17 -0.94 -0.57 - -905 -0.25 -0.26 - -0.17 -254 -395 - -0.19 -0.33 -0.2 - -0.09 -0.07 - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
1.33 -905 -47.3